A phase I study of decitabine and rapamycin in relapsed/refractory AML.
Liesveld JL, O'Dwyer K, Walker A, Becker MW, Ifthikharuddin JJ, Mulford D, Chen R, Bechelli J, Rosell K, Minhajuddin M, Jordan CT, Phillips GL 2nd.
Liesveld JL, et al.
Leuk Res. 2013 Dec;37(12):1622-7. doi: 10.1016/j.leukres.2013.09.002. Epub 2013 Sep 8.
Leuk Res. 2013.
PMID: 24138944
Clinical Trial.